1 Product identity
Ingredient risk
Contains a high-risk ingredient
FemRebalance
BrandVitanica→Botanical with Nutrients Capsule 13 ingredients 1 high-risk 1 caution DSLD #33444Net contents: 60 Vegetarian Capsule(s)
Target: Adults and Children 4 years and above
DSLD entry: 2014-05-23
2 Ingredients (13)
IngredientGroupSafety
LicoriceLicorice —
Chaste TreeChastetree—
Borage oil powder extractBorage Oil—
VervainVervain (unspecified)—
Sarsaparilla root extractSarsaparilla—
Vegetable CelluloseCellulose—
WaterWater—
Ingredient amounts require the full DSLD label. View full label at NIH DSLD →
⛔ High-risk ingredient — documented serious harm
Black Cohosh 🇺🇸 🇦🇺 🇪🇺 — Hepatotoxicity cases including liver failure — limit 6 months [1]
⚠️ Use with caution — restricted in some markets
Maca 🇺🇸 🇰🇷 🇪🇺 — ood. Dietary supplement [1]. || European Union :: Novel food ingredient [1]. || South Korea :: Dietary supplement. || Ma
3 Safety cross-reference
Rhodiola — Conditionally Safe
⚠ Insomnia if taken late
⚠ MAOI-like activity
Maca — Use with Caution
⚠ Goitrogenic
⚠ Hormonal effects
Wild Yam — Conditionally Safe
⚠ Does NOT convert to progesterone in body despite marketing claims
⚠ Estrogenic effects
Black Cohosh — High risk
⚠ HEPATOTOXICITY (rare but serious)
⚠ Limit to 6 months
L-Leucine — Limited Evidence
⚠ May worsen pellagra
⚠ High doses may impair glucose metabolism
Silicon — Generally Safe
⚠ Very low toxicity
4 Label claims
• All Other
• Structure/Function
5 Data source
DSLD ID33444
Full labelView at NIH DSLD →
SourceOffice of Dietary Supplements, NIH
Market statusOn market
Entry date2014-05-23
6 More from Vitanica
View Vitanica Safety Scorecard → 44 products
Bitters ExtraBitters ExtraBlack CohoshBlack CohoshBreast Cycle BlendButterbur Extra7 Cite this page
Vancouver
Pkhakadze G. FemRebalance — product analysis [Internet]. Tbilisi: Public Health Institute of Georgia; 2026 [cited 2026 Aug 26]. Available from: https://supplement.ge/products/femrebalance-33444/
CC BY 4.0. Product data from NIH DSLD; safety analysis by SupplementIndex.
GP
Analyzed by SupplementIndex
PHIG · Editor-in-Chief: Prof. Giorgi Pkhakadze, MD, MPH, PhD
Product data sourced from the NIH Dietary Supplement Label Database (DSLD). Safety cross-referencing by SupplementIndex. This analysis is for informational purposes only. For corrections: info@accreditation.ge.
Publisher: PHIG
Publisher: PHIG